Skip Content

Dr Gunnel Hallden

Dr Gunnel HalldenResearch Institution: Barts Cancer Institute, Queen Mary University of London

Award: £200,000   Duration: 3 years

Project Title: Identification of drugs that promote activation of the host anti-cancer immune responses through enhancement of virus-mediated cell lysis

Project Aims: Dr Halldén is progressing her PCRF-funded research which aims to use a flu-like virus, delivered into the bloodstream, to seek out and infect pancreatic cancer cells wherever they are in the body. This project will identify new drugs that improve the ability of the virus to replicate inside the cancer cells and spread within the tumour, which should stimulate the immune system to provide long-term protection from the disease coming back.